PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.00 - 0.01
0.00 - 0.02
1.30M / 496.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
187.83%
Revenue growth above 1.5x ANO.AX's 62.13%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
141.82%
Gross profit growth at 50-75% of ANO.AX's 251.94%. Martin Whitman would question if cost structure or brand is lagging.
1131.48%
EBIT growth above 1.5x ANO.AX's 155.25%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
1131.48%
Operating income growth above 1.5x ANO.AX's 648.74%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
682.71%
Net income growth above 1.5x ANO.AX's 161.71%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
500.00%
EPS growth above 1.5x ANO.AX's 161.29%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
500.00%
Diluted EPS growth above 1.5x ANO.AX's 161.54%. David Dodd would see if there's a robust moat protecting these shareholder gains.
-3.85%
Share reduction while ANO.AX is at 0.62%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-2.97%
Reduced diluted shares while ANO.AX is at 0.46%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
-1723.26%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-4204.46%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-31.83%
Negative 10Y revenue/share CAGR while ANO.AX stands at 223.10%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
221.27%
Positive 5Y CAGR while ANO.AX is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
105.69%
3Y revenue/share CAGR above 1.5x ANO.AX's 6.96%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
-277.17%
Negative 10Y OCF/share CAGR while ANO.AX stands at 77.99%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-424.53%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-668.10%
Negative 3Y OCF/share CAGR while ANO.AX stands at 878.66%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
408.00%
Below 50% of ANO.AX's 4293.06%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
500.00%
Positive 5Y CAGR while ANO.AX is negative. John Neff might view this as a strong mid-term relative advantage.
60.00%
Positive short-term CAGR while ANO.AX is negative. John Neff would see a clear advantage in near-term profit trajectory.
No Data
No Data available this quarter, please select a different quarter.
1831.22%
5Y equity/share CAGR above 1.5x ANO.AX's 53.02%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
116.58%
3Y equity/share CAGR above 1.5x ANO.AX's 0.05%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
219.76%
AR growth well above ANO.AX's 53.52%. Michael Burry fears inflated revenue or higher default risk in the near future.
-7.99%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
28.58%
Asset growth above 1.5x ANO.AX's 3.20%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
27.93%
BV/share growth above 1.5x ANO.AX's 2.14%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
51.86%
We have some new debt while ANO.AX reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
-100.00%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
15.25%
SG&A growth well above ANO.AX's 14.86%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.